Literature DB >> 10525450

Dendritic cells as natural adjuvants.

S Citterio1, M Rescigno, M Foti, F Granucci, D Aggujaro, C Gasperi, M K Matyszak, G Girolomoni, P Ricciardi-Castagnoli.   

Abstract

Dendritic cells (DCs) are professional antigen presenting cells that hold the key to the induction of T-cell responses. Therefore, the use of DCs for immunotherapy to stimulate immune responses has recently raised a great deal of interest. Many clinical trials using DCs have been initiated to stimulate immune responses against tumors or infectious agents. Several issues need to be considered before DCs can be used successfully as natural adjuvants: DCs have to be generated in sufficient numbers; they should display morphological, phenotypical, and functional properties of DCs; and they should be able to present antigens. In the present review we focus on methods for the purification of DCs from human bone marrow and peripheral blood and for the optimization of in vitro cell culture systems. Methods to generate growth factor-dependent mouse DC lines are also described. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525450     DOI: 10.1006/meth.1999.0839

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  5 in total

1.  Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo.

Authors:  Joanne M Fraser; Claire N Janicki; Ben J E Raveney; David J Morgan
Journal:  Immunology       Date:  2006-06-23       Impact factor: 7.397

Review 2.  Dendritic Cells as an Alternate Approach for Treatment of Neurodegenerative Disorders.

Authors:  Veronika Brezovakova; Bernadeta Valachova; Jozef Hanes; Michal Novak; Santosh Jadhav
Journal:  Cell Mol Neurobiol       Date:  2018-06-13       Impact factor: 5.046

3.  Tumour necrosis factor-alpha but not lipopolysaccharide enhances preference of murine dendritic cells for Th2 differentiation.

Authors:  Kazuhiro Kikuchi; Yoshiki Yanagawa; Toshimasa Aranami; Chikako Iwabuchi; Kazuya Iwabuchi; Kazunori Onoé
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

4.  Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses.

Authors:  M Rescigno; V Piguet; B Valzasina; S Lens; R Zubler; L French; V Kindler; J Tschopp; P Ricciardi-Castagnoli
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

5.  Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses.

Authors:  Zhujun Ao; Lijun Wang; Emelissa J Mendoza; Keding Cheng; Wenjun Zhu; Eric A Cohen; Keith Fowke; Xiangguo Qiu; Gary Kobinger; Xiaojian Yao
Journal:  PLoS One       Date:  2019-05-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.